SWK (NASDAQ:SWKH - Get Free Report) is anticipated to announce its Q1 2025 earnings results before the market opens on Thursday, May 15th. Analysts expect the company to announce earnings of $0.29 per share for the quarter.
SWK (NASDAQ:SWKH - Get Free Report) last issued its quarterly earnings results on Wednesday, March 19th. The company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.40). SWK had a net margin of 26.51% and a return on equity of 5.07%. The business had revenue of $12.36 million during the quarter, compared to analyst estimates of $9.70 million.
SWK Stock Performance
NASDAQ SWKH traded down $0.05 on Friday, reaching $13.41. The stock had a trading volume of 11,176 shares, compared to its average volume of 12,746. The company has a market cap of $164.54 million, a P/E ratio of 14.42 and a beta of 0.21. The company has a debt-to-equity ratio of 0.11, a current ratio of 5.06 and a quick ratio of 5.06. SWK has a 1-year low of $13.17 and a 1-year high of $20.49. The firm has a fifty day moving average of $16.39 and a two-hundred day moving average of $16.38.
SWK Announces Dividend
The company also recently disclosed a dividend, which was paid on Thursday, May 8th. Stockholders of record on Thursday, April 24th were given a dividend of $4.00 per share. The ex-dividend date was Thursday, April 24th.
SWK Company Profile
(
Get Free Report)
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.
Featured Stories
Before you consider SWK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SWK wasn't on the list.
While SWK currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
